Nonstructural protein 5A/P32 deletion after failure of ledipasvir/sofosbuvir in hepatitis C virus genotype 1b infection

被引：17
|
作者：
Doi, Akira [1 ]
Hikita, Hayato [1 ]
Sakamori, Ryotaro [1 ]
Tahata, Yuki [1 ]
Kai, Yugo [1 ]
Yamada, Ryoko [1 ]
Yakushijin, Takayuki [2 ]
Mita, Eiji [3 ]
Ohkawa, Kazuyoshi [4 ]
Imai, Yasuharu [5 ]
Furuta, Kunimaro [1 ]
Kodama, Takahiro [1 ]
Tatsumi, Tomohide [1 ]
Takehara, Tetsuo [1 ]
机构：
[1] Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan
[2] Osaka Gen Med Ctr, Dept Gastroenterol & Hepatol, Osaka, Japan
[3] Osaka Natl Hosp, Natl Hosp Org, Dept Gastroenterol & Hepatol, Osaka, Japan
[4] Osaka Int Canc Inst, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan
[5] Ikeda Municipal Hosp, Ikeda, Osaka, Japan
来源：
HEPATOLOGY | 2018年 / 68卷 / 01期
关键词：
D O I：
10.1002/hep.29836
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：380 / 383
页数：4
相关论文
共 50 条
  • [31] The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus
    Sáiz, JC
    López-Labrador, FX
    Ampurdanés, S
    Dopazo, J
    Forns, X
    Sánchez-Tapias, JM
    Rodés, J
    JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04): : 839 - 847
  • [32] Treatment with sofosbuvir and ledipasvir without ribavirin for 12 weeks is highly effective for recurrent hepatitis C virus genotype 1b infection after living donor liver transplantation: a Japanese multicenter experience
    Yoshihide Ueda
    Toru Ikegami
    Nobuhisa Akamatsu
    Akihiko Soyama
    Masahiro Shinoda
    Ryoichi Goto
    Hideaki Okajima
    Tomoharu Yoshizumi
    Akinobu Taketomi
    Yuko Kitagawa
    Susumu Eguchi
    Norihiro Kokudo
    Shinji Uemoto
    Yoshihiko Maehara
    Journal of Gastroenterology, 2017, 52 : 986 - 991
  • [33] Treatment with sofosbuvir and ledipasvir without ribavirin for 12 weeks is highly effective for recurrent hepatitis C virus genotype 1b infection after living donor liver transplantation: a Japanese multicenter experience
    Ueda, Yoshihide
    Ikegami, Toru
    Akamatsu, Nobuhisa
    Soyama, Akihiko
    Shinoda, Masahiro
    Goto, Ryoichi
    Okajima, Hideaki
    Yoshizumi, Tomoharu
    Taketomi, Akinobu
    Kitagawa, Yuko
    Eguchi, Susumu
    Kokudo, Norihiro
    Uemoto, Shinji
    Maehara, Yoshihiko
    JOURNAL OF GASTROENTEROLOGY, 2017, 52 (08) : 986 - 991
  • [34] Mutations in the nonstructural protein 5A gene in chronic hepatitis C virus in infection patients with interferon treatment
    Niiyama, G
    Kimura, T
    Mitani, K
    Tsugeno, H
    Sengoku, N
    Kinoyama, S
    Ito, T
    Kinoshita, M
    Yamada, G
    HEPATOLOGY, 1996, 24 (04) : 150 - 150
  • [35] Differential effect of interferon on hepatitis C virus 1b quasispecies in the nonstructnral protein 5A gene
    Sakuma, I
    Enomoto, N
    Kurosaki, M
    Izumi, N
    Marumo, F
    Sato, C
    JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (04): : 1001 - 1009
  • [36] Mutations in nonstructural region 5b of hepatitis C virus genotype 1b and its relation to viral load.
    Watanabe, K
    Yoshioka, K
    Ito, H
    Ukai, K
    Yano, M
    HEPATOLOGY, 2000, 32 (04) : 543A - 543A
  • [37] Retreatment with sofosbuvir/ledipasvir with or without lead-in interferon- injections in patients infected with genotype 1b hepatitis C virus after unsuccessful daclatasvir/asunaprevir therapy
    Uemura, Hayato
    Uchida, Yoshihito
    Kouyama, Jun-ichi
    Naiki, Kayoko
    Yamaba, Shinpei
    Fuchigami, Akira
    Saito, Yoichi
    Shiokawa, Keisuke
    Fujii, Yohei
    Uchiya, Hiroshi
    Nakazawa, Manabu
    Ando, Satsuki
    Nakao, Masamitsu
    Motoya, Daisuke
    Sugawara, Kayoko
    Inao, Mie
    Imai, Yukinori
    Nakayama, Nobuaki
    Tomiya, Tomoaki
    Mochida, Satoshi
    HEPATOLOGY RESEARCH, 2018, 48 (04) : 233 - 243
  • [38] Efficacy and changes of the nonstructural 5A gene by prolonged interferon therapy for patients with hepatitis C virus genotype 1b and a high level of serum HCV-RNA
    Arase, Y
    Ikeda, K
    Chayama, K
    Murashima, N
    Tsubota, A
    Suzuki, Y
    Saitoh, S
    Kobayashi, H
    Kobayashi, M
    Kobayashi, M
    Kumada, H
    INTERNAL MEDICINE, 1999, 38 (06) : 461 - 466
  • [39] Ledipasvir-Sofosbuvir: A Once-Daily Oral Treatment Option for Chronic Hepatitis C Virus Genotype 1 Infection
    Jensen, Christopher M.
    Holle, Lisa M.
    PHARMACOTHERAPY, 2016, 36 (05): : 562 - 574
  • [40] Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV)
    Brown, Ashley N.
    Liu, Lin
    Rodriquez, Jaime L.
    Zhao, Lisa
    Schuster, Layla
    Li, Eric
    Wang, Gary P.
    Neely, Michael N.
    Yamada, Walter
    Drusano, George L.
    SCIENTIFIC REPORTS, 2017, 7
12345